abrdn plc grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 89.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,764,107 shares of the biopharmaceutical company’s stock after acquiring an additional 1,772,887 shares during the quarter. Gilead Sciences […]
Roman Butler Fullerton & Co Sells 240 Shares of Gilead Sciences, Inc (NASDAQ:GILD) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences (NASDAQ:GILD – Free Report) had its price target decreased by UBS Group from $81.00 to $75.00 in a report issued on Wednesday, Benzinga reports. UBS Group currently has a neutral rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Oppenheimer lowered their price objective on Gilead […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by UBS Group from $81.00 to $75.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on the company. Oppenheimer cut […]
Gilead Sciences, Inc (NASDAQ:GILD) Shares Acquired by Perigon Wealth Management LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.